Retractable Technologies, Inc. (NYSE:RVP)

Wednesday, June 2, 2021 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($10.06; $342.0M market cap) (medical device;safety syringes) announced (yesterday during...
Tuesday, May 18, 2021 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($12.82; $433.5M market cap) (medical device;safety syringes) announced Q1 2021 results:...
Tuesday, November 17, 2020 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($8.39; $282.2M market cap) (medical device) announced Q3 2020 results:...
See All Research...
Tuesday, March 10, 2020, 3:16 PM
Retractable Technologies Inc: A Better Mousetrap That Needs Market Traction
See All Articles and Reports...
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Web site: http://www.retractable.com

Last updated June 14, 2021